FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:883-884 September 29, 1994 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Mark, D. B.

To the Editor: The use of immunosuppressive agents after organ transplantation is associated with an increased risk of lymphoproliferative disorders related to Epstein-Barr virus (EBV)¹. The risk of these disorders with immunosuppressive therapy for other conditions, such as inflammatory bowel disease, is not well established. We describe a patient in whom a reversible EBV-related lymphoproliferative disease developed during treatment with azathioprine for Crohn's disease.

A 33-year-old man had a 13-year history of Crohn's disease involving the whole small bowel. Because the disease was steroid-dependent, azathioprine therapy was started (100 mg per day) in April 1988. After steroids were withdrawn, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.